Abvc Biopharma (ABVC) Cash & Current Investments (2010 - 2026)
Abvc Biopharma (ABVC) reported Cash & Current Investments of $94,364 for Q2 2026, down 79.2% from $453,462 a year earlier and down 53.4% from the prior quarter.
Powered by 
Analysis
Abvc Biopharma (ABVC) Cash & Current Investments (2010 - 2026) Analysis & Trends
At the end of FY2025, Abvc Biopharma posted Cash & Current Investments of $745,834, up 138.2% from FY2024.
- Cash & Current Investments has a five-year compound annual growth rate of -29.5% (FY2020 to FY2025).
- By year, Cash & Current Investments came in at $313,118 in FY2024 (+124.5%), $139,467 in FY2023 (-90.5%), $1.47 million in FY2022 (-78.0%) and $6.67 million in FY2021 (+56.2%).
- The Q2 2026 figure ranks as the lowest quarterly Cash & Current Investments since Q3 2018.
- Year over year, Cash & Current Investments gained in four of the last eight quarters, with growth averaging 21.8%.
- The high point for year-over-year Cash & Current Investments in five years was Q2 2022 (growth of 223.7%); the low point was Q2 2023 (a decline of 94.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $202,509 (Q1 2026), $745,834 (Q4 2025) and $257,243 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Abvc Biopharma | 26.80 Mn | 27.48 Mn | - | 94,364.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 94,364.00 |
| Mar 31, 2026 | 202,509.00 |
| Dec 31, 2025 | 745,834.00 |
| Sep 30, 2025 | 257,243.00 |
| Jun 30, 2025 | 453,462.00 |
| Mar 31, 2025 | 217,258.00 |
| Dec 31, 2024 | 313,118.00 |
| Sep 30, 2024 | 208,153.00 |
| Jun 30, 2024 | 199,979.00 |
| Mar 31, 2024 | 734,918.00 |
| Dec 31, 2023 | 139,467.00 |
| Sep 30, 2023 | 1.19 Mn |
| Jun 30, 2023 | 176,077.00 |
| Mar 31, 2023 | 1.87 Mn |
| Dec 31, 2022 | 1.47 Mn |
| Sep 30, 2022 | 2.05 Mn |
| Jun 30, 2022 | 2.99 Mn |
| Mar 31, 2022 | 2.81 Mn |
| Dec 31, 2021 | 6.67 Mn |
| Sep 30, 2021 | 3.83 Mn |
API Access
Abvc Biopharma Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ABVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "ABVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ABVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();